NovelStem International Corp.
www.novelstem.comNovelStem International Corp., formerly Hollywood Media Corp., provides Stem Cell-Based Diagnostic technology. The Company has developed diagnostic technology that can predict patients' resistance to chemotherapy to allow for better, targeted cancer treatments with the potential to reduce incidents of chemotherapy resistance. The Company's diagnostic solutions are based on the research of human haploid pluripotent stem cells and enables informed, personalized selection of chemotherapy treatments for cancer patients. Its genetic screenings are performed on haploid cells to provide a opportunity to identify the genes responsible for resistance to chemotherapeutic agents.
Read moreNovelStem International Corp., formerly Hollywood Media Corp., provides Stem Cell-Based Diagnostic technology. The Company has developed diagnostic technology that can predict patients' resistance to chemotherapy to allow for better, targeted cancer treatments with the potential to reduce incidents of chemotherapy resistance. The Company's diagnostic solutions are based on the research of human haploid pluripotent stem cells and enables informed, personalized selection of chemotherapy treatments for cancer patients. Its genetic screenings are performed on haploid cells to provide a opportunity to identify the genes responsible for resistance to chemotherapeutic agents.
Read moreCountry
Industry
Employees
11-50
Founded
2018
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chairman
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Independant Director
Email ****** @****.comPhone (***) ****-****
Technologies
(12)